Omega Healthcare Investors Inc (NYSE:OHI) COO Daniel J. Booth sold 25,000 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $42.95, for a total value of $1,073,750.00. Following the completion of the sale, the chief operating officer now owns 174,986 shares in the company, valued at $7,515,648.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Omega Healthcare Investors stock opened at $44.32 on Friday. The firm has a 50 day simple moving average of $42.66 and a 200 day simple moving average of $41.59. The company has a current ratio of 2.67, a quick ratio of 3.00 and a debt-to-equity ratio of 1.18. Omega Healthcare Investors Inc has a 1-year low of $34.64 and a 1-year high of $45.01. The firm has a market capitalization of $9.40 billion, a price-to-earnings ratio of 28.05, a P/E/G ratio of 6.19 and a beta of 0.39.
Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Wednesday, February 5th. The real estate investment trust reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.10). Omega Healthcare Investors had a return on equity of 8.38% and a net margin of 36.73%. The company had revenue of $212.18 million for the quarter, compared to analysts’ expectations of $204.40 million. During the same quarter in the prior year, the company earned $0.73 EPS. The company’s revenue was up 12.7% on a year-over-year basis. On average, equities research analysts forecast that Omega Healthcare Investors Inc will post 3.13 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Friday, January 31st were paid a dividend of $0.67 per share. The ex-dividend date was Thursday, January 30th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.05%. Omega Healthcare Investors’s payout ratio is 87.30%.
OHI has been the topic of a number of recent research reports. Wells Fargo & Co reaffirmed a “hold” rating on shares of Omega Healthcare Investors in a research report on Monday, December 9th. Citigroup began coverage on Omega Healthcare Investors in a report on Wednesday, January 22nd. They issued a “neutral” rating and a $44.00 price objective for the company. Mizuho assumed coverage on Omega Healthcare Investors in a research note on Thursday, December 19th. They issued a “buy” rating and a $50.00 price objective on the stock. Zacks Investment Research downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Wednesday, January 8th. Finally, Raymond James lowered shares of Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a research report on Monday, October 21st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $44.50.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Cubist Systematic Strategies LLC increased its position in shares of Omega Healthcare Investors by 65.3% in the second quarter. Cubist Systematic Strategies LLC now owns 1,653 shares of the real estate investment trust’s stock valued at $61,000 after acquiring an additional 653 shares during the last quarter. BlackRock Inc. raised its holdings in Omega Healthcare Investors by 2.5% during the second quarter. BlackRock Inc. now owns 24,907,576 shares of the real estate investment trust’s stock worth $915,351,000 after acquiring an additional 600,319 shares in the last quarter. Genesee Capital Advisors LLC boosted its position in Omega Healthcare Investors by 10.6% during the third quarter. Genesee Capital Advisors LLC now owns 23,815 shares of the real estate investment trust’s stock valued at $995,000 after purchasing an additional 2,282 shares during the last quarter. Bay Harbor Wealth Management LLC boosted its position in Omega Healthcare Investors by 26.7% during the third quarter. Bay Harbor Wealth Management LLC now owns 5,146 shares of the real estate investment trust’s stock valued at $218,000 after purchasing an additional 1,086 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in Omega Healthcare Investors by 18.1% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 9,819 shares of the real estate investment trust’s stock valued at $410,000 after purchasing an additional 1,505 shares in the last quarter. 76.07% of the stock is currently owned by institutional investors and hedge funds.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Recommended Story: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.